Furthermore, studies performed on NSCLC in A549 cells showed that the miR-206 antagomir therapy decreased tumor volume and the formation of intra-tumoral capillary tubes, and increased apoptosis by blocking the 14-3-3zeta/STAT3/HIF-1alpha/VEGF signaling pathway [31]. This evidence concerns the gene VEGFA and non-small cell lung carcinoma.